BIONANO GENOMICS INC's ticker is BNGO and the CUSIP is 09075F107. A total of 119 filers reported holding BIONANO GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,855,326 | -51.4% | 14,516,927 | -11.5% | 0.00% | – |
| Q1 2023 | $18,216,147 | -22.3% | 16,410,943 | +2.2% | 0.00% | -100.0% |
| Q4 2022 | $23,454,088 | -18.6% | 16,064,444 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $28,813,000 | +33.5% | 15,744,729 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $21,576,000 | -47.3% | 15,634,397 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $40,961,000 | -7.6% | 15,876,289 | +7.1% | 0.00% | 0.0% |
| Q4 2021 | $44,329,000 | -46.5% | 14,825,634 | -1.5% | 0.00% | -50.0% |
| Q3 2021 | $82,793,000 | -24.0% | 15,053,272 | +1.3% | 0.00% | -33.3% |
| Q2 2021 | $108,890,000 | +45.0% | 14,855,436 | +59.8% | 0.00% | +50.0% |
| Q1 2021 | $75,109,000 | +241.9% | 9,295,839 | +30.3% | 0.00% | +100.0% |
| Q4 2020 | $21,969,000 | +507.2% | 7,132,899 | +28.1% | 0.00% | – |
| Q3 2020 | $3,618,000 | +1898.9% | 5,566,305 | +1469.0% | 0.00% | – |
| Q2 2020 | $181,000 | +96.7% | 354,773 | +76.2% | 0.00% | – |
| Q1 2020 | $92,000 | – | 201,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 368,943 | $952,000 | 0.27% |
| QCM Cayman, Ltd. | 10,568 | $27,000 | 0.12% |
| CPR Investments Inc. | 29,687 | $77,000 | 0.06% |
| Cutter & CO Brokerage, Inc. | 62,700 | $162,000 | 0.05% |
| Kalos Management, Inc. | 26,620 | $68,000 | 0.05% |
| Archford Capital Strategies, LLC | 79,483 | $206,000 | 0.05% |
| Platform Technology Partners | 31,450 | $81,000 | 0.04% |
| CIM INVESTMENT MANAGEMENT INC | 26,657 | $69,000 | 0.02% |
| Bank Julius Baer & Co. Ltd, Zurich | 1,396,938 | $3,604,000 | 0.02% |
| Golden State Equity Partners | 17,037 | $44,000 | 0.02% |